IR vs TNXP · P/E 49, rev $3.90B vs rev $20.4M
Ingersoll Rand Inc (IR) versus Tonix Pharmaceuticals Holding Corp (TNXP) — a side-by-side from cached financials, not a winner call.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.
Latest reported IR revenue for 2026-06-30 was $3.90B. Net income was $448.9M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Latest reported TNXP revenue for 2026-06-30 was $20.4M. Net income was -$80.7M. TNXP currently screens at market cap $194.5M.
IR currently screens at market cap $28.27B and trailing P/E 48.8. TNXP currently screens at market cap $194.5M.
Not investment advice. Open the IR and TNXP stock pages for the full models.
Not investment advice.